Tech Company Financing Transactions
HistoSonics Funding Round
Founders Fund and private investors participated in a $250 million venture round for HistoSonics. The financing was announced on 10/16/2025.
Transaction Overview
Company Name
Announced On
10/16/2025
Transaction Type
Venture Equity
Amount
$250,000,000
Round
Undisclosed
Investors
private investors (Thiel Bio)
Proceeds Purpose
The financing will support the ongoing commercial expansion of HistoSonics' Edison System into new global markets, accelerate new clinical indications throughout the body, and strengthen operational capacity for the next phase of growth.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
3526 West Liberty Rd. 100
Ann Arbor, MI 48103
USA
Ann Arbor, MI 48103
USA
Phone
Website
Email Address
Overview
HistoSonics Inc. is a new medical device company that is developing histotripsy, a non-invasive, image-guided therapeutic ultrasound technology.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Michael Blue
Chief Financial Officer
Eric Bosler
Vice President
Michele Bossert
VP - Marketing
Josh King
VP - Operations
Daniel Bulver
VP - R & D
Josh Stopek
VP - Regulatory Affairs
Daniel Kosednar
VP - Sales
Jonathon Pons
Browse more venture capital transactions:
Prev: 10/16/2025: Bees & Bears venture capital transaction
Next: 10/16/2025: Upgrade venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC transactions on this site come from a variety of public sources. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs